Arthur Herbst to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Arthur Herbst has written about Uterine Cervical Neoplasms.
Connection Strength
2.965
-
Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix. N Engl J Med. 2018 05 03; 378(18):1746-1748.
Score: 0.522
-
Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecol Oncol. 2017 09; 146(3):566-571.
Score: 0.493
-
The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note. Obstet Gynecol. 2001 Nov; 98(5 Pt 1):849-51.
Score: 0.166
-
Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. Am J Obstet Gynecol. 2016 09; 215(3):322.e1-8.
Score: 0.112
-
Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2015 Apr; 24(4):308-15.
Score: 0.105
-
DES exposure: an update. Contemp Pediatr. 1994 Nov; 11(11):59-62, 64, 66 passim.
Score: 0.102
-
Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994 Sep; 84(3):404-8.
Score: 0.101
-
Clear cell adenocarcinoma of the lower genital tract. Correlation of mother's recall of diethylstilbestrol history with obstetrical records. Cancer. 1990 Nov 15; 66(10):2215-20.
Score: 0.078
-
Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol. 1990; 6(6):343-6.
Score: 0.073
-
Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol. 1989 Sep; 34(3):413-6.
Score: 0.072
-
Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. J Low Genit Tract Dis. 2008 Apr; 12(2):111-7.
Score: 0.065
-
Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 1988 Jan; 29(1):76-81.
Score: 0.064
-
An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma. Am J Obstet Gynecol. 1987 Aug; 157(2):433-9.
Score: 0.062
-
Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med. 1987 Feb 26; 316(9):514-6.
Score: 0.060
-
The effects in the human of diethylstilbestrol (DES) use during pregnancy. Princess Takamatsu Symp. 1987; 18:67-75.
Score: 0.059
-
Clear cell adenocarcinoma (CCA) of the vagina and cervix in association with pregnancy. Gynecol Oncol. 1986 Jun; 24(2):207-19.
Score: 0.057
-
Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol. 1986 Apr; 154(4):814-22.
Score: 0.056
-
Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. Gynecol Oncol. 1983 Apr; 15(2):230-8.
Score: 0.046
-
DES-related female genital changes. Semin Oncol. 1982 Sep; 9(3):341-8.
Score: 0.044
-
Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control. 2001 Nov; 12(9):837-45.
Score: 0.042
-
Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer. 1981 Jul 15; 48(2 Suppl):484-8.
Score: 0.041
-
The current status of the DES-exposed population. Obstet Gynecol Annu. 1981; 10:267-78.
Score: 0.039
-
Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1979 Dec 01; 135(7):876-86.
Score: 0.036
-
DES-associated clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol Surv. 1979 Nov; 34(11):844.
Score: 0.036
-
Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monogr. 1979 May; (51):25-35.
Score: 0.035
-
An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol. 1979 Apr; 7(2):111-22.
Score: 0.035
-
Preoperative intracavitary brachytherapy in early-stage cervical carcinoma. Am J Clin Oncol. 1999 Feb; 22(1):73-7.
Score: 0.034
-
Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1977 May 01; 128(1):43-50.
Score: 0.030
-
Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des). J Reprod Med. 1975 Jul; 15(1):13-18.
Score: 0.027
-
The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. J Reprod Med. 1975 Jul; 15(1):5-11.
Score: 0.027
-
Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol. 1974 Jul 01; 119(5):713-24.
Score: 0.025
-
Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 1994 Jun 15; 271(23):1866-9.
Score: 0.025
-
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21; 287(25):1259-64.
Score: 0.022
-
The Bethesda system for cervical/vaginal cytologic diagnoses. Clin Obstet Gynecol. 1992 Mar; 35(1):22-7.
Score: 0.021
-
Diethylstilbestrol exposure--1984. N Engl J Med. 1984 Nov 29; 311(22):1433-5.
Score: 0.013
-
Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer. 1984 Sep 01; 54(5):869-75.
Score: 0.013
-
A quality-control procedure on cervical lesions for the comparison of cytology and histology. J Reprod Med. 1983 Dec; 28(12):811-22.
Score: 0.012
-
Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. Obstet Gynecol. 1982 Nov; 60(5):546-51.
Score: 0.011
-
Accuracy of three sampling technics for the diagnosis of endometrial cancer and hyperplasias. J Reprod Med. 1982 Oct; 27(10):622-6.
Score: 0.011
-
Clear cell adenocarcinoma of the vagina and cervix in black females. J Natl Med Assoc. 1982 Jul; 74(7):639-43.
Score: 0.011
-
Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters. Am J Obstet Gynecol. 1981 Dec 15; 141(8):1019-28.
Score: 0.010
-
Diethylstilbestrol and other sex hormones during pregnancy. Obstet Gynecol. 1981 Nov; 58(5 Suppl):35S-40S.
Score: 0.010
-
DES update. Interview by Arthur I. Holleb. CA Cancer J Clin. 1980 Nov-Dec; 30(6):326-32.
Score: 0.010
-
Comparison of histologic and colposcopic findings in DES-exposed females. Obstet Gynecol. 1978 Oct; 52(4):457-61.
Score: 0.008
-
Evaluation and management of diethylstilbestrol-exposed offspring. Surg Clin North Am. 1978 Feb; 58(1):87-96.
Score: 0.008
-
Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Cancer Res. 1977 Apr; 37(4):1249-51.
Score: 0.008
-
Angiographic control of pelvic bleeding from treated carcinoma of the cervix. Gynecol Oncol. 1976 Jun; 4(2):144-50.
Score: 0.007
-
Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy. J Toxicol Environ Health Suppl. 1976; 1:13-20.
Score: 0.007
-
Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer. 1974 Sep; 34(3):606-14.
Score: 0.006
-
Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. Acta Cytol. 1974 Jul-Aug; 18(4):279-90.
Score: 0.006